These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 10079000

  • 1. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats.
    Culman J, von Heyer C, Piepenburg B, Rascher W, Unger T.
    Eur J Pharmacol; 1999 Feb 19; 367(2-3):255-65. PubMed ID: 10079000
    [Abstract] [Full Text] [Related]

  • 2. Functional evidence for the ability of angiotensin AT1 receptor antagonists to cross the blood-brain barrier in rats.
    Polidori C, Ciccocioppo R, Pompei P, Cirillo R, Massi M.
    Eur J Pharmacol; 1996 Jul 04; 307(3):259-67. PubMed ID: 8836613
    [Abstract] [Full Text] [Related]

  • 3. Effects of irbesartan (SR47436/BMS-186295) on angiotensin II-induced pressor responses in the pithed rat: potential mechanisms of action.
    Christophe B, Libon R, Cazaubon C, Nisato D, Manning A, Chatelain P.
    Eur J Pharmacol; 1995 Aug 04; 281(2):161-71. PubMed ID: 7589203
    [Abstract] [Full Text] [Related]

  • 4. Effect of the AT1-receptor antagonists losartan, irbesartan, and telmisartan on angiotensin II-induced facilitation of sympathetic neurotransmission in the rat mesenteric artery.
    Balt JC, Mathy MJ, Nap A, Pfaffendorf M, van Zwieten PA.
    J Cardiovasc Pharmacol; 2001 Jul 04; 38(1):141-8. PubMed ID: 11444497
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
    Lacour C, Canals F, Galindo G, Cazaubon C, Segondy D, Nisato D.
    Eur J Pharmacol; 1994 Nov 03; 264(3):307-16. PubMed ID: 7698170
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of angiotensin II-induced facilitation of sympathetic neurotransmission in the pithed rat: a comparison between losartan, irbesartan, telmisartan, and captopril.
    Balt JC, Mathy MJ, Pfaffendorf M, van Zwieten PA.
    J Hypertens; 2001 Mar 03; 19(3):465-73. PubMed ID: 11288817
    [Abstract] [Full Text] [Related]

  • 7. Effects of U-97018 on pressor responses to intracerebroventricularly administered angiotensin II in conscious normotensive rats.
    Morita O, Kushida H, Kunihara M.
    J Cardiovasc Pharmacol; 1995 Jun 03; 25(6):880-7. PubMed ID: 7564332
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of angiotensin, AT1 and AT2 receptors in the pressor, drinking and vasopressin responses to central angiotensin.
    Hogarty DC, Speakman EA, Puig V, Phillips MI.
    Brain Res; 1992 Jul 24; 586(2):289-94. PubMed ID: 1521162
    [Abstract] [Full Text] [Related]

  • 10. The selective angiotensin AT1 receptor antagonist LR-B/081 potently inhibits drinking induced by central injection of angiotensin II in rats.
    Polidori C, Ciccocioppo R, Pompei P, Cirillo R, Massi M.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):223-8. PubMed ID: 7493612
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist binding.
    Fierens FL, Vanderheyden PM, De Backer JP, Vauquelin G.
    Eur J Pharmacol; 1999 May 14; 372(2):199-206. PubMed ID: 10395100
    [Abstract] [Full Text] [Related]

  • 13. Effects of blockade of AT1 and AT2 receptors in brain on the central angiotensin II pressor response in conscious spontaneously hypertensive rats.
    Toney GM, Porter JP.
    Neuropharmacology; 1993 Jun 14; 32(6):581-9. PubMed ID: 8336821
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of the ability of irbesartan to cross the blood-brain barrier following acute intragastric treatment.
    Polidori C, Ciccocioppo R, Nisato D, Cazaubon C, Massi M.
    Eur J Pharmacol; 1998 Jul 03; 352(1):15-21. PubMed ID: 9718262
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Losartan potassium, a nonpeptide antagonist of angiotensin II, chronically administered p.o. does not readily cross the blood-brain barrier.
    Bui JD, Kimura B, Phillips MI.
    Eur J Pharmacol; 1992 Aug 14; 219(1):147-51. PubMed ID: 1397042
    [Abstract] [Full Text] [Related]

  • 18. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.
    Mazzolai L, Maillard M, Rossat J, Nussberger J, Brunner HR, Burnier M.
    Hypertension; 1999 Mar 14; 33(3):850-5. PubMed ID: 10082498
    [Abstract] [Full Text] [Related]

  • 19. Functional roles of brain AT1 and AT2 receptors in the central angiotensin II pressor response in conscious young spontaneously hypertensive rats.
    Toney GM, Porter JP.
    Brain Res Dev Brain Res; 1993 Feb 19; 71(2):193-9. PubMed ID: 8491041
    [Abstract] [Full Text] [Related]

  • 20. Angiotensin AT1 receptor-mediated vasopressin release and drinking are potentiated by an AT2 receptor antagonist.
    Höhle S, Spitznagel H, Rascher W, Culman J, Unger T.
    Eur J Pharmacol; 1995 Mar 14; 275(3):277-82. PubMed ID: 7768295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.